指南与共识神经儿科影像MR

新生儿筛查发现的X连锁肾上腺脑白质营养不良男童的MRI监测:Meta分析与共识指南

MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines.
指南 / 共识 · J Inherit Metab Dis · 2021-01-09

该共识指南基于123项研究1285例患者的Meta分析,确定儿童脑型肾上腺脑白质营养不良(CCALD)诊断平均年龄7.91岁,中位年龄7.0岁(IQR 6.0-9.5,n=349),90%在3至12岁间诊断。专家小组以95.7%共识率推荐系列脑MRI监测方案:12-18月龄首次MRI,基线后1年第二次,3-12岁每6个月增强MRI,12岁后每年一次。

要点

  • CCALD诊断中位年龄7.0岁,90%在3至12岁间诊断,该年龄段为监测重点。
  • 推荐12-18月龄首次MRI,基线后1年复查第二次MRI。
  • 3-12岁每6个月行增强MRI,12岁后每年一次MRI。

关键影像表现/征象

  • 常规MRI最常被报告,最常包括T2加权和增强T1加权MRI。

诊断标准与关键数值

  • CCALD诊断总体平均年龄7.91岁。
  • CCALD诊断中位年龄7.0岁(IQR 6.0-9.5,n=349)。
  • 90%患者诊断年龄在3至12岁之间。
  • 专家小组对以下监测参数达成95.7%共识:(a)12至18月龄之间获得MRI;(b)基线后1年获得第二次MRI;(c)3至12岁之间每6个月获得增强MRI;(d)12岁后每年获得MRI。

临床应用与阅片要点

  • 对新生儿筛查发现的肾上腺脑白质营养不良男童,按共识推荐的时机和序列进行系列脑MRI监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Among boys with X-Linked adrenoleukodystrophy, a subset will develop childhood cerebral adrenoleukodystrophy (CCALD). CCALD is typically lethal without hematopoietic stem cell transplant before or soon after symptom onset. We sought to establish evidence-based guidelines detailing the neuroimaging surveillance of boys with neurologically asymptomatic adrenoleukodystrophy.

METHODS: To establish the most frequent age and diagnostic neuroimaging modality for CCALD, we completed a meta-analysis of relevant studies published between January 1, 1970 and September 10, 2019. We used the consensus development conference method to incorporate the resulting data into guidelines to inform the timing and techniques for neuroimaging surveillance. Final guideline agreement was defined as >80% consensus.

RESULTS: One hundred twenty-three studies met inclusion criteria yielding 1285 patients. The overall mean age of CCALD diagnosis is 7.91 years old. The median age of CCALD diagnosis calculated from individual patient data is 7.0 years old (IQR: 6.0-9.5, n = 349). Ninety percent of patients were diagnosed between 3 and 12. Conventional MRI was most frequently reported, comprised most often of T2-weighted and contrast-enhanced T1-weighted MRI. The expert panel achieved 95.7% consensus on the following surveillance parameters: (a) Obtain an MRI between 12 and 18 months old. (b) Obtain a second MRI 1 year after baseline. (c) Between 3 and 12 years old, obtain a contrast-enhanced MRI every 6 months. (d) After 12 years, obtain an annual MRI.

CONCLUSION: Boys with adrenoleukodystrophy identified early in life should be monitored with serial brain MRIs during the period of highest risk for conversion to CCALD.

来源:J Inherit Metab Dis,查看原文。版权归原作者所有。

引用

  1. Mallack EJ, Turk BR, Yan H, et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J Inherit Metab Dis. 2021. PMID: 33373467. doi:10.1002/jimd.12356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。